Companies / VRTX vs ZTS
VRTX vs ZTS: Vertex Pharmaceuticals and Zoetis
Vertex Pharmaceuticals (VRTX) reported $12.0B in revenue against a 32.9% net margin, while Zoetis (ZTS) reported $9.5B at a 28.2% net margin, most recently.
| Metric | VRTX | ZTS |
|---|---|---|
| Revenue | $12.0B | $9.5B |
| Net Income | $4.0B | $2.7B |
| Gross Margin | 86.2% | 71.8% |
| Operating Margin | 34.8% | — |
| EPS (Diluted) | $15.32 | $6.02 |
| Free Cash Flow | $3.2B | $2.3B |
| Total Debt | — | $9.0B |
| P/E Ratio | 29.6× | 20.9× |
| P/B Ratio | 6.2× | 16.1× |
| Stock Price | $542.69 | $82.13 |
Free: last 5 years
| Fiscal year | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VRTX Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $7.6B | $8.9B | $9.9B | $11.0B | $12.0B |
| ZTS Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $7.8B | $8.1B | $8.5B | $9.3B | $9.5B |